Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

mAbs

Showing results (791-800 of 1,834) with videos related to

Pageof 184
Sort By:
Mabs|February 23, 2023
Strategies for clinical dose optimization of T cell-engaging therapies in oncologyKathryn Ball, Simon J Dovedi, Pavan Vajjah, et al.
Mabs|November 16, 2022
Clearance of therapeutic antibody glycoforms after subcutaneous and intravenous injection in a porcine modelDavid Falck, Martin Lechmann, Ana Momčilović, et al.
Mabs|December 12, 2025
Fine-tuning affinity and spacer design enhances T cell potency in DLL3 and BCMA CAR T cellsNicholas Mazzanti, Ninkka Tamot, Andrea Francese, et al.
Mabs|December 12, 2025
Rapid expression of therapeutic antibodies in mammalian cells via mRNA transfectionThornwit Chavalparit, Craig Barry, Helen Gunter, et al.
Mabs|October 4, 2012
Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein productsQingqiao Tan, Qingcheng Guo, Chen Fang, et al.
Mabs|October 4, 2012
FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian populationJulien Lejeune, Benoît Piègu, Valérie Gouilleux-Gruart, et al.
Mabs|April 15, 2022
The eIg technology to generate Ig-like bispecific antibodiesLennart Kühl, Nadine Aschmoneit, Roland E Kontermann, et al.
Mabs|May 23, 2014
Small scale affinity purification and high sensitivity reversed phase nanoLC-MS N-glycan characterization of mAbs and fusion proteinsFabian Higel, Andreas Seidl, Uwe Demelbauer, et al.
Mabs|May 23, 2014
Delivery of antibodies to the cytosol: debunking the mythsAndrea L J Marschall, Congcong Zhang, André Frenzel, et al.
Mabs|May 27, 2014
Antibodies directed against receptor tyrosine kinases: current and future strategies to fight cancerBénédicte Fauvel, Aziz Yasri
Pageof 184

Showing results (791-800 of 1,834) with videos related to

Sort By:
Pageof 184
Mabs|February 23, 2023
Strategies for clinical dose optimization of T cell-engaging therapies in oncologyKathryn Ball, Simon J Dovedi, Pavan Vajjah, et al.
Mabs|November 16, 2022
Clearance of therapeutic antibody glycoforms after subcutaneous and intravenous injection in a porcine modelDavid Falck, Martin Lechmann, Ana Momčilović, et al.
Mabs|December 12, 2025
Fine-tuning affinity and spacer design enhances T cell potency in DLL3 and BCMA CAR T cellsNicholas Mazzanti, Ninkka Tamot, Andrea Francese, et al.
Mabs|December 12, 2025
Rapid expression of therapeutic antibodies in mammalian cells via mRNA transfectionThornwit Chavalparit, Craig Barry, Helen Gunter, et al.
Mabs|October 4, 2012
Characterization and comparison of commercially available TNF receptor 2-Fc fusion protein productsQingqiao Tan, Qingcheng Guo, Chen Fang, et al.
Mabs|October 4, 2012
FCGR2C genotyping by pyrosequencing reveals linkage disequilibrium with FCGR3A V158F and FCGR2A H131R polymorphisms in a Caucasian populationJulien Lejeune, Benoît Piègu, Valérie Gouilleux-Gruart, et al.
Mabs|April 15, 2022
The eIg technology to generate Ig-like bispecific antibodiesLennart Kühl, Nadine Aschmoneit, Roland E Kontermann, et al.
Mabs|May 23, 2014
Small scale affinity purification and high sensitivity reversed phase nanoLC-MS N-glycan characterization of mAbs and fusion proteinsFabian Higel, Andreas Seidl, Uwe Demelbauer, et al.
Mabs|May 23, 2014
Delivery of antibodies to the cytosol: debunking the mythsAndrea L J Marschall, Congcong Zhang, André Frenzel, et al.
Mabs|May 27, 2014
Antibodies directed against receptor tyrosine kinases: current and future strategies to fight cancerBénédicte Fauvel, Aziz Yasri
Pageof 184